Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B46/00—Surgical drapes
  • A61B46/30—Surgical drapes for surgery through the lower body openings, e.g. urology, gynaecology
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
  • A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
  • A61B90/40—Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
  • A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
  • A61B17/07292—Reinforcements for staple line, e.g. pledgets
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive

Definitions

• the invention relates to medical devices, in particular condoms and drains, that find use in anastomosis.
• the condoms/drains of the present invention are for example made of biodegradable polyurethanes, in particular polyurethanes comprising poly(ether)ester pre-polymer soft segments and polyurethane hard segments.
• the present invention relates to these medical devices per se, to a medical kit comprising these medical devices, to the use of these medical devices, to a method for medical treatment involving application of these medical devices to an organism who is in need thereof as well as to the use of certain biocompatible, biodegradable synthetic polymers in the preparation of a medical device for the treatment of a disease or a condition which requires anastomosis.
• Anastomosis the operation of joining two ends of biological vessels, such as the oesophagus, colon or other parts of the gastro -digestive channel, is often accompanied by complications. For instance, the most important complication and cause of death following low anterior resection involving the colorectal segment is anastomotic leakage. In many cases re-interventions are needed to treat the complications. Leakage may occur as the result of dehiscence of the anastomosis itself or of the tissue of the digestive channel just proximal or particularly distal of the anastomosis. This may occur typically approximately at around five days after the creation of the , anastomosis.
• FIG. 1 schematically shows a cross-section of a condom of the present invention prior to application to the site of anastomosis.
• Figure 2 schematically shows a cross-section condom of the present invention at the time it is applied to the site where the anastomosis is to be performed.
• Figure 3 schematically shows a cross-section of a condom of the present invention at the time it is brought into place in the proximal part of a lumen, prior to stapling.
• Figure 4 schematically shows a cross-section of a condom of the present invention just after the staphng has been carried out but prior to the cutting of an annulus.
• Figure 5 schematically shows a cross-section of a condom of the present invention at the time the stapling is carried out and the cap is removed from the staphng site.
• Figure 6 schematically shows a cross-section of a condom of the present invention at the time it is stretched to its final length and position.
• Figure 7 is a schematic cross-sectional representation, illustrating the position of the staple relative to the device of the present invention and the two ends of the connected lumen.
• Figure 8 schematically shows the use of a circular stapler as it is known in the art.
• Figure 9 schematically shows a staple for use known in the art and also with the present invention. It also shows a pattern in which the staples may be applied.
• Figure 10 is an impression of a condom according to the present invention.
• the present invention is directed to a medical device for the protection of an anastomosis, which device comprises a tubular shaped part which is made of a biocompatible, biodegradable polymer.
• biodegradable as used herein, means that the material decomposes or looses structural integrity under the conditions it is applied (i.e., in the body). It may thus fragment and leave the body via the natural pathway.
• the device of the present invention is preferably in the shape of a condom, viz. having one open end and one closed end.
• a small opening or perforation may be provided in the closed end of the condom of the present invention so as to facilitate the introduction of a stapling cap, as will explained in more detail hereinbelow. It is a very important property of the devices of the present invention that composition of the biodegradable polymer can be chosen such that a desired and controllable fragmentation behavior, in particular degradation rate, can be obtained.
• Suitable materials for the condoms or otherwise shaped devices of the present invention are described in WO-A-2004/039424.
• Particularly suitable polymer compositions are biodegradable polyurethanes .
• the preferred polyurethane is composed of a poly(ether)ester pre-polymer soft segment and a polyurethane hard segment with a structure -BDI-BDO-BDI-BDO-BDI- (BDI being 1,4- butanedhsocyanate and BDO being 1,4-butanediol).
• the preferred polyether is a polyethyleneglycol. The rate of degradation of the polyurethane will depend on the initial molecular weight (measured by the intrinsic viscosity) and the chemical composition of the pre-polymer.
• the pre-polymer for this application is preferably based on DL-lactide and ⁇ -caprolactone and has a molecular weight of preferably 1500-2300, more preferably 2000. It may be obtained by a ring opening polymerisation initiated by 1,4-butanediol combined with the polyether compound.
• the preferred monomer ratio is from 50/50 to 70/30 (mol/mol).
• the PEG content in the polyurethane is preferably between 1-25 wt.% for applications in the digestive tract, more preferably from 5 to 20 wt.%. In particular, for graspal anastomosis the PEG content is preferably between 2-10 wt.%.
• the molecular weight of PEG is preferably between 600-2000 and is mo'st preferably 1000.
• the device of the present invention is manufactured by a spray-coating process comprising the steps of providing a solution of a biocompatible, biodegradable polymer, preferably of the above-mentioned type in a suitable solvent.
• suitable solvents are organic solvents, in particular halogenated (in particular chlorated) or non-halogenated lower (typically Cx- C 4 ) hydrocarbons (in particular ethers), such as chloroform, dichloromethane, tetrahydrofuran, dioxane and the like.
• the concentration of the solution is typically from 1 to 10 wt.%, preferably from 2 to 7 wt.%, e.g. about 4 wt.%.
• the solution is then spraycoated using a known device to a rotating mandrel, which is made from a hard material, e.g. a ceramic material such as glass.
• the mandrel may have a roughened surface.
• the solvent is allowed to evaporate.
• the wall thickness of the device will depend on the amount of polymer solution sprayed on the mandrel.
• the mandrel and the polymeric layer are submerged in a suitable liquid, such as (distilled) water.
• the devices of the present invention can be obtained by removing them from the mandrel and cutting them to the desired shape and size and after drying for some time, typically several hours, up to 24 hours, preferably under vacuum at slightly elevated temperatures, such as 25 to 50 °C, preferably at about 40 °C.
• the device of the present invention is suitably manufactured by the following typical spraycoating process wherein the polyurethane as described above is dissolved in a suitable solvent, e.g. chloroform (or dichloromethane, tetrahydrofuran, dioxane, and the like or combinations thereof), ca. 4 wt. %.
• the polymer solution is spray coated on a horizontally placed and rotating glass mandrel (surface is roughened).
• the device of the present invention in particular a condom, preferably has one or more of the following dimensions: a length of 15 to 35 cm (more preferably 25 ⁇ 2 cm); a diameter of 15 to 50 mm (more preferably 35 ⁇ 5 mm); and a wall thickness of 50 to 90 ⁇ m (more preferably 70 ⁇ 15 ⁇ m).
• the biodegradable devices of the present invention may be used to perform anastomosis. To this end it is highly preferred that it is used in combination with a stapler, in particular with a so-called circular stapler.
• Staplers have been widely accepted for use in colorectal surgery since their introduction in 1975 as an alternative to hand made sutures and are responsible for the increase in the number of procedures in ultra low anterior rectum resection (see Thiede A.; "Rectal stapler. A simple instrument for alleviating reconstruction of the colorectal passage in the pelvis"; Chirurg. 63(1992) 72-3).
• the devices of the present invention can be used in combination with these circular staplers.
• FIG 8 the use of these known circular stapler devices is illustrated: after the cap and stapler are assembled, and the two sections of intestine are ahgned, the stapler is closed and fired. Before proceeding to remove the circular stapler, the adjusting knob should be slightly opened to facilitate the extraction of the stapler.
• the staples that are suitable for use in the present invention may be made of metal, such as stainless steel, titanium, titanium alloys or cobalt-base alloys, as known in the art. It may also be possible to provide these staples from biodegradable materials, such as biodegradable polymers having the suitable mechanical properties, in particular a suitable ductility. In principle, any glue may be used to glue the condom to cap (2), since the glue does not contact the body.
• the glue is a cyanoacrylate based glue, which is a typical instant glue for skin applications, e.g. DermabondTM, (JNJ, USA) or IndermilTM (Tyco, USA).
• the device of the present invention may thus be used as a drain for different purposes, such as a colorectal drain.
• the device of the present invention typically supports the newly formed anastomosis for 10 to 15 days by preventing contact between the anastomosis and the contents of the lumen (e.g. the colorectal contents) so that the fresh wound can heal, thereby reducing the chance of complications related to leakage.
• the device may be stapled together with the distal and proximal section of the lumen e.g.
• the open end (top in Figure 1) of a drain or condom of the invention (1) is fixed to a stapler cap (2), e.g. using glue (3) that is applied to the top of the cap (2).
• Figure 1 is a cross section and therefore the flaps, as depicted in Figure 10, are not visible.
• the condom has flaps, which are attached to cap (2), as discussed in more detail hereinbelow. Fixation can be achieved e.g. by using a cyanoacrylate glue. Because the glue does not come in contact with the body, these skin-glues as well as other types of glue can be used safely as long as the glue connection is strong enough to pull out the condom (see also
• the cap and device according to the present invention are preferably dry before the application of glue for optimal adhesion.
• the cap (2) is moved in the direction indicated by the arrow in Figure 1.
• the pin shaped bottom end of the cap is pierced through the closed end (bottom in Figure 1) of the condom.
• a hole or a perforation may be present in the condom to facilitate puncturing of the condom.
• the assembly (condom (1) glued to cap (2)) is then inserted in the proximal section of the intestine (5), see Figure 2. It is ensured that the drain is placed upward and not folded at the site of the pin.
• the proximal intestine (5) is closed around the connecting pin
• a stapler device in particular a circular stapler (7) is inserted in the distal end of the intestine (6).
• the stapler (7) also has a connecting pin, which fits on the connecting pin of the cap (2), e.g. by the stapler (7) having a female pin and the cap (2) having a male pin, so that both cap (2) and stapler (7) can be connected.
• the stapler (7) is further provided with staples (8) and an annular knife (9) to cut the intestine and the condom, see also Figures 8 and 9.
• the pin (2) is connected to the stapler device (7).
• both ends of the intestine and the condom (2) are connected in one single staple action. Also a circular portion of the intestine and the condom is cut out leaving an opening as indicated by the dashed line (9').
• the drain according to the present invention is firmly attached at the proximal end of the intestinal wall by the staples. After the staphng procedure the cap with the condom still fixed to it is pulled through the opening indicated by (9') in a direction further proximal to the anastomosis, as illustrated in Figure 5. The drain is thereby pulled inside out.
• Figure 6 illustrates the situation wherein the condom is in its proper position to protect the anastomosis.
• the condom (1) is cut to remove the cap (2). It may be cut at a suitable position, indicated by dashed line (10'). This may be at a position before or after the anal sphincter. Depending on the position of the anastomosis and, upon the discretion of the operator, the loose end may be drawn through the anal sphincter. In case it is too long, or the operator may want to leave it in place on the inside only, it can be cut to the appropriate length. To avoid obstruction of the drain, e.g. due to torsion, the patency of the drain should be checked directly after placement.
• a medical kit comprises a device as defined above and typically instructions for use. It may further comprise one or more staples, preferably biodegradable staples. It may further comprise a stapling cap, a stapler and/or glue (e.g. a cyanoacrylate glue as mentioned hereinabove).
• the known staplers typically apply a double-staggered circular line of staples, as is illustrated in Figure 9b, showing a typical double-staggered pattern.
• Figure 9a shows how the staple height may vary in the course of application.
• the cutting line is cut out (transected) by knives (9) upon which the tissue within the circle is removed.
• the condoms of the present invention may have one or more flaps on the open end to facilitate gluing to the cap.
• Figure 10 shows such a preferred embodiment, wherein the condom is provided with two flaps on the top end.
• flaps may have a length that is typically about the same size as the diameter of the condom, e.g. 30 mm.
• the condom is shaped at the open end as a sinusoid, making two full periods around the circumference of the condom, as illustrated in Figure 10.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Surgery (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Biomedical Technology (AREA)
• Heart & Thoracic Surgery (AREA)
• Medical Informatics (AREA)
• Molecular Biology (AREA)
• Animal Behavior & Ethology (AREA)
• Engineering & Computer Science (AREA)
• Public Health (AREA)
• Urology & Nephrology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Pathology (AREA)
• Orthopedics, Nursing, And Contraception (AREA)
• Materials For Medical Uses (AREA)
• Surgical Instruments (AREA)
• Polysaccharides And Polysaccharide Derivatives (AREA)

Priority Applications (7)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (1)

Family

ID=34928180

Family Applications (1)

Country Status (11)

Families Citing this family (22)

Citations (7)

Family Cites Families (25)

• 2004
  • 2004-04-20 EP EP04076251A patent/EP1588667A1/en not_active Withdrawn
• 2005
  • 2005-04-20 DK DK11150200.1T patent/DK2347723T3/da active
  • 2005-04-20 AT AT05737561T patent/ATE533412T1/de active
  • 2005-04-20 CA CA2563474A patent/CA2563474C/en not_active Expired - Fee Related
  • 2005-04-20 PL PL11150200T patent/PL2347723T3/pl unknown
  • 2005-04-20 AU AU2005235161A patent/AU2005235161B2/en not_active Ceased
  • 2005-04-20 CN CN201310403644.0A patent/CN103536329A/zh active Pending
  • 2005-04-20 CN CNA2005800118021A patent/CN1953711A/zh active Pending
  • 2005-04-20 EP EP11150200A patent/EP2347723B1/en not_active Expired - Lifetime
  • 2005-04-20 WO PCT/NL2005/000290 patent/WO2005102182A1/en not_active Ceased
  • 2005-04-20 JP JP2007509409A patent/JP5273705B2/ja not_active Expired - Fee Related
  • 2005-04-20 ES ES11150200T patent/ES2405529T3/es not_active Expired - Lifetime
  • 2005-04-20 ES ES05737561T patent/ES2377504T3/es not_active Expired - Lifetime
  • 2005-04-20 EP EP05737561A patent/EP1746941B1/en not_active Expired - Lifetime
• 2006
  • 2006-10-16 US US11/581,793 patent/US7776081B2/en not_active Expired - Fee Related

Patent Citations (7)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events